Literature DB >> 17303245

Acute bilateral uveitis associated with an active human herpesvirus-6 infection.

Jérôme Maslin1, Christine Bigaillon, Françoise Froussard, Vincent Enouf, Elisabeth Nicand.   

Abstract

Human herpesvirus 6 (HHV-6), which is usually responsible for exanthem subitum in children, can reactivate from its latent form after primary infection. It has been implicated in hepatitis, pneumonitis, retinitis and severe infections of the central nervous system in both immunosuppressed and immunocompetent patients. However, involvement of HHV-6 in these infections has not yet been clearly demonstrated. We report the case of a patient presenting a bilateral uveitis from whom HHV-6 was isolated in both aqueous fluid and cerebrospinal fluid (CSF). No other pathogenic agents were found. Diagnosis by polymerase chain reaction (PCR) followed by sequencing of part of the genome revealed the presence of HHV-6 in both aqueous fluid and CSF. Serum IgM and IgG HHV-6 antibodies were significantly elevated in two successive examinations by immunofluorescence. Patient recovery following antiviral therapy suggested that a protocol based on foscarnet followed by ganciclovir was effective. HHV-6 may be responsible for uveo-meningitis. Diagnosis by PCR analysis is essential to identify HHV-6 and to initiate a specific antiviral therapy as fast as possible.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303245     DOI: 10.1016/j.jinf.2006.12.012

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  10 in total

1.  Human herpesvirus 6-associated uveitis with optic neuritis diagnosed by multiplex PCR.

Authors:  Nahoko Ogata; Naoko Koike; Tadanobu Yoshikawa; Kanji Takahashi
Journal:  Jpn J Ophthalmol       Date:  2011-08-04       Impact factor: 2.447

2.  Human herpesvirus 6-A, 6-B, and 7 in vitreous fluid samples.

Authors:  Jeffrey I Cohen; Gary Fahle; Margaret A Kemp; Kathleen Apakupakul; Todd P Margolis
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

3.  Identification of cytomegalovirus and human herpesvirus-6 DNA in a patient with corneal endotheliitis.

Authors:  Hideaki Yokogawa; Akira Kobayashi; Natsuko Yamazaki; Kazuhisa Sugiyama
Journal:  Jpn J Ophthalmol       Date:  2012-12-18       Impact factor: 2.447

4.  Has the polymerase chain reaction come of age for ophthalmology?

Authors:  Russell N Van Gelder
Journal:  Am J Ophthalmol       Date:  2009-01       Impact factor: 5.258

5.  Ocular pathogens for the twenty-first century.

Authors:  Russell N Van Gelder
Journal:  Am J Ophthalmol       Date:  2010-11       Impact factor: 5.258

6.  Identification of new pathogens in the intraocular fluid of patients with uveitis.

Authors:  Jolanda D F de Groot-Mijnes; Lenneke de Visser; Stephanie Zuurveen; Roaldy A Martinus; René Völker; Ninette H ten Dam-van Loon; Joke H de Boer; Gina Postma; Raoul J de Groot; Anton M van Loon; Aniki Rothova
Journal:  Am J Ophthalmol       Date:  2010-08-05       Impact factor: 5.258

Review 7.  Ocular manifestations of emerging viral diseases.

Authors:  Ashwin Venkatesh; Ravi Patel; Simran Goyal; Timothy Rajaratnam; Anant Sharma; Parwez Hossain
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

8.  A case of bilateral human herpes virus 6 panuveitis with genomic viral DNA integration.

Authors:  Jasmina Bajric; Wendy M Smith
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-06-19

9.  Multiplex polymerase chain reaction for pathogen detection in donor/recipient corneal transplant tissue and donor storage solution.

Authors:  Takehiro Hariya; Kazuichi Maruyama; Sunao Sugita; Masayo Takahashi; Shunji Yokokura; Kota Sato; Yasuhiro Tomaru; Norio Shimizu; Toru Nakazawa
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

10.  Long-term outcome in corneal endotheliitis with molecular detection of herpes simplex virus 1 and human herpes virus 6: a case report.

Authors:  Takashi Ono; Takuya Iwasaki; Yukiko Terada; Yosai Mori; Ryohei Nejima; Mineo Ozaki; Manabu Mochizuki; Kazunori Miyata
Journal:  BMC Ophthalmol       Date:  2022-02-02       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.